EMBECTA CORP. Earnings Per Share (Basic)
EMBECTA CORP. (EMBC) reported Earnings Per Share (Basic) of $0.36 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasic · last filed 2026-08-07
- EMBECTA CORP. earnings per share, basic for the quarter ending 2026-06-30 was $0.36, a 53.85% decline year-over-year.
- EMBECTA CORP. earnings per share, basic for the quarter ending 2026-03-31 was -$0.07, a 117.50% decline year-over-year.
- EMBECTA CORP. earnings per share, basic for the quarter ending 2025-12-31 was $0.75.
- EMBECTA CORP. earnings per share, basic for the quarter ending 2025-09-30 was $0.45, a 78.60% increase year-over-year.
- EMBECTA CORP. earnings per share, basic for fiscal 2025 was $1.64, a 20.59% increase from fiscal 2024.
- EMBECTA CORP. earnings per share, basic for fiscal 2024 was $1.36, a 10.57% increase from fiscal 2023.
- EMBECTA CORP. earnings per share, basic for fiscal 2023 was $1.23, a 68.62% decline from fiscal 2022.
- EMBECTA CORP. earnings per share, basic for fiscal 2022 was $3.92, a 46.15% decline from fiscal 2021.
| Period end | Earnings Per Share, Basic 3 month | Earnings Per Share, Basic 6 month | Earnings Per Share, Basic 9 month | Earnings Per Share, Basic 12 month |
|---|---|---|---|---|
| 2026-06-30 | $0.36 10-Q · filed 2026-08-07 | $0.29 derived: net income ÷ weighted average shares · filed 2026-08-07 | $1.04 10-Q · filed 2026-08-07 | $1.49 derived: net income ÷ weighted average shares · filed 2026-08-07 |
| 2026-03-31 | -$0.07 10-Q · filed 2026-05-05 | $0.68 10-Q · filed 2026-05-05 | $1.13 derived: net income ÷ weighted average shares · filed 2026-05-05 | $1.90 derived: net income ÷ weighted average shares · filed 2026-08-07 |
| 2025-12-31 | $0.75 10-Q · filed 2026-02-05 | $1.20 derived: net income ÷ weighted average shares · filed 2026-02-05 | $1.98 derived: net income ÷ weighted average shares · filed 2026-08-07 | $2.38 derived: net income ÷ weighted average shares · filed 2026-08-07 |
| 2025-09-30 | $0.45 derived: net income ÷ weighted average shares · filed 2025-11-25 | $1.23 derived: net income ÷ weighted average shares · filed 2026-08-07 | $1.63 derived: net income ÷ weighted average shares · filed 2026-08-07 | $1.64 10-K · filed 2025-11-25 |
| 2025-06-30 | $0.78 10-Q · filed 2026-08-07 | $1.18 derived: net income ÷ weighted average shares · filed 2026-08-07 | $1.18 10-Q · filed 2026-08-07 | $1.44 derived: net income ÷ weighted average shares · filed 2026-08-07 |
| 2025-03-31 | $0.40 10-Q · filed 2026-05-05 | $0.40 10-Q · filed 2026-05-05 | $0.66 derived: net income ÷ weighted average shares · filed 2026-05-05 | $0.91 derived: net income ÷ weighted average shares · filed 2026-05-05 |
| 2024-12-31 | $0.00 10-Q · filed 2026-02-05 | $0.25 derived: net income ÷ weighted average shares · filed 2026-02-05 | $0.51 derived: net income ÷ weighted average shares · filed 2026-02-05 | $1.01 derived: net income ÷ weighted average shares · filed 2026-02-05 |
| 2024-09-30 | $0.25 derived: net income ÷ weighted average shares · filed 2025-11-25 | $0.51 derived: net income ÷ weighted average shares · filed 2025-11-25 | $1.01 derived: net income ÷ weighted average shares · filed 2025-11-25 | $1.36 10-K · filed 2025-11-25 |
| 2024-06-30 | $0.25 10-Q · filed 2025-08-08 | $0.76 derived: net income ÷ weighted average shares · filed 2025-08-08 | $1.11 10-Q · filed 2025-08-08 | $1.21 derived: net income ÷ weighted average shares · filed 2025-11-25 |
| 2024-03-31 | $0.50 10-Q · filed 2025-05-09 | $0.85 10-Q · filed 2025-05-09 | $0.96 derived: net income ÷ weighted average shares · filed 2025-11-25 | $1.22 derived: net income ÷ weighted average shares · filed 2025-11-25 |
| 2023-12-31 | $0.35 10-Q · filed 2025-02-06 | $0.45 derived: net income ÷ weighted average shares · filed 2025-11-25 | $0.72 derived: net income ÷ weighted average shares · filed 2025-11-25 | $0.96 derived: net income ÷ weighted average shares · filed 2025-11-25 |
| 2023-09-30 | $0.10 derived: net income ÷ weighted average shares · filed 2025-11-25 | $0.37 derived: net income ÷ weighted average shares · filed 2025-11-25 | $0.61 derived: net income ÷ weighted average shares · filed 2025-11-25 | $1.23 10-K · filed 2025-11-25 |
| 2023-06-30 | $0.27 10-Q · filed 2024-08-09 | $0.51 derived: net income ÷ weighted average shares · filed 2024-08-09 | $1.13 10-Q · filed 2024-08-09 | $0.83 derived: net income ÷ weighted average shares · filed 2024-12-11 |
| 2023-03-31 | $0.24 10-Q · filed 2024-05-09 | $0.86 10-Q · filed 2024-05-09 | $0.57 derived: net income ÷ weighted average shares · filed 2024-12-11 | $1.66 derived: net income ÷ weighted average shares · filed 2024-12-11 |
| 2022-12-31 | $0.62 10-Q · filed 2024-02-09 | $0.32 derived: net income ÷ weighted average shares · filed 2024-12-11 | $1.42 derived: net income ÷ weighted average shares · filed 2024-12-11 | $2.81 derived: net income ÷ weighted average shares · filed 2024-12-11 |
| 2022-09-30 | -$0.31 derived: net income ÷ weighted average shares · filed 2024-12-11 | $0.80 derived: net income ÷ weighted average shares · filed 2024-12-11 | $2.20 derived: net income ÷ weighted average shares · filed 2024-12-11 | $3.92 10-K · filed 2024-12-11 |
| 2022-06-30 | $1.08 10-Q · filed 2023-08-08 | $2.46 derived: net income ÷ weighted average shares · filed 2023-08-08 | $4.17 10-Q · filed 2023-08-08 | $5.94 derived: net income ÷ weighted average shares · filed 2023-11-29 |
| 2022-03-31 | $1.38 10-Q · filed 2023-05-12 | $3.09 10-Q · filed 2023-05-12 | $4.87 derived: net income ÷ weighted average shares · filed 2023-11-29 | $6.69 derived: net income ÷ weighted average shares · filed 2023-11-29 |
| 2021-12-31 | $1.73 10-Q · filed 2023-02-14 | $3.50 derived: net income ÷ weighted average shares · filed 2023-11-29 | $5.32 derived: net income ÷ weighted average shares · filed 2023-11-29 | $7.19 derived: net income ÷ weighted average shares · filed 2023-11-29 |
| 2021-09-30 | $1.77 derived: net income ÷ weighted average shares · filed 2023-11-29 | $3.59 derived: net income ÷ weighted average shares · filed 2023-11-29 | $5.45 derived: net income ÷ weighted average shares · filed 2023-11-29 | $7.28 10-K · filed 2023-11-29 |
| 2021-06-30 | $1.81 10-Q · filed 2022-08-15 | $3.68 derived: net income ÷ weighted average shares · filed 2022-08-15 | $5.50 10-Q · filed 2022-08-15 | |
| 2021-03-31 | $1.87 10-Q · filed 2022-05-13 | $3.69 10-Q · filed 2022-05-13 | ||
| 2020-09-30 | $7.50 10-K · filed 2022-12-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| SHOULDER INNOVATIONS, INC. (SI) | United States | $0.355B | |
| Orchestra BioMed Holdings, Inc. (OBIO) | United States | $0.356B | -4.39 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| Orthofix Medical Inc. (OFIX) | $0.373B | ||
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |